Exam 2 Study Guide Flashcards
Insulins
- Rapid-acting: Lispro & Aspart
- Short: Regular
- Long-acting: Glargine
Glucose Elevating Agents
- Intravenous D50W
- Glucagon
Non-Insulin (Oral)
- Metformin
- Glipizide
- Empagliflozin
- Sitagliptin
Non-Insulin (SQ)
Liraglutide
Non-Insulin Agents MOA
- Incr insulin release
- Dcr glucagon release
- Slow GI absorption of glucose
- Blocks glucose reabsorption in kidneys; excretes more glucose in urine
Insulin Compatibilities
- Lispro/Aspart + Regular or NPH
> Lispro + Regular
> Lispro + NPH
> Aspart + Regular
> Aspart + NPH - Insulin Detemir alone
- Insulin Glargine alone
- Do not mix a premixed insulin w/ any other insulin
> Novocain 70/30
> Humulin 50/50 - Why? Med orders are @ same time
> use diff sites if cannot mix
Mixing Insulin
- Gently roll cloudy insulin vial btwn hands
- Give mixed insulins w/in 5 mins
- Inject air into vials equaling units to be administered
- Withdraw CLEAR insulin 1st (regular or rapid) followed by CLOUDY (intermediate-NPH)
Metformin (Biguanides)
MOA
Indication
Route
AE
Nursing
- MOA:
> incrs insulin SENSITIVITY
> dcrs hepatic glucose production
> dcrs GI glucose absorption - Indications: T2DM
- Route: oral
- AE: GI effects (N/V/D); dcrs w/ time; lactic acidosis (rare but serious)
- Nursing: low risk for hypoglycemia, HOLD 2 days prior & 2 days after IV contrast (risk for AKI)
Glipizide (Sulfonylureas, 2nd Gen)
MOA
Route
Caution
AE
Nursing
- MOA:
> incrs insulin SECRETION
> incrs insulin receptor sensitivity
> dcrs hepatic production glucose - Route: oral
- Caution: sulfa allergy
- AE: Hypoglycemia, skin rash; hypoglycemia more likely if: low calories, prolonged exercise, alcohol, other DM meds, older adults
- Nursing: take w/ meal
Empagliflozin (Jardiance) (Sodium Glucose Cotransporter Inhibitors - SGLT2 Inhibitors)
MOA
Route
AE
- MOA: Blocks glucose REABSORPTION in kidney, thus excreting more glucose (blocks Na/K pump in kidney; responsible for 90% of glucose reabsorption)
- Route: oral
- AE: UTI, genital fungal infection, dehydration & associated symptoms
Liraglutide (Victoza) (Incretin Mimetics/GLP-1 Agonists)
MOA
Route
AE
Nursing
- MOA: acts on beta cells to incr insulin RELEASE; dcrs glucagon release; slow gastric emptying; incr satiety
- Route: SQ (daily)
- AE: hypoglycemia, N/V/D, weight loss
- Nursing: teach self-injection
- sometimes prescribed for weight loss
- good to study w/ sitagliptin
Sitagliptin (Januvia) (Dipeptidyl Peptidase {DDP-IV} Inhibitors)
MOA
Route
AE
Nursing
- MOA: slows breakdown of GLP-1 leading to incrd insulin RELEASE & dcrd glucagon release
- Route: oral
- AE: hypoglycemia w/ sulfonylurea
- Nursing: general hypoglycemic protocol
GLP-1 Agonist
- Glucagon-like peptide 1
- GLP-1 is released from gut during digestion
- GLP-1 inhibits glucagon secretion & incrs insulin secretion
Dipeptidyl Peptidase (DDP-IV) Inhibitor
- An enzyme that breaks down incretins (like GLP-1)
- Help stimulate the release of insulin when need (after meals) & reduce the production of glucagon when it is not needed
Glucagon (Glucose-Elevating Agents)
MOA
Route
Onset
AE
Nursing
- MOA: accelerates the breakdown of glycogen to glucose in the liver, causing an incr in blood glucose lvls
- Route: IM or SQ
- Onset: 1 min; WORKS QUICKLY
- AE: hyperglycemia, rebound hypoglycemia
- Nursing:
> admin SQ/IM if no IV access for severe hypoglycemia
> give supplemental carbos to replenish depleted glycogen stores
> monitor: VS, LOC, BG (rebound hypoglycemia)
Intravenous Dextrose 50% in Water (D50W) (Glucose-Elevating Agents)
- MOA: incr circulating blood glucose
- Route: IV push over 2-5mins
- Onset: minutes
- AE: hyperglycemia, electrolyte disturbances, hyperosmolarity; localized phlebitis, localized tissue necrosis - must have patent IV
- Nursing:
> admin IV (need patency) for severe hypoglycemia
> give supplemental carbos when pt able to swallow safely to replenish depleted glycogen
> monitor: VS, LOC, BG
Rapid Acting Insulin
- Lispro (Humalog) & Aspart (Novolog)
- Onset: 0.25hrs/15mins
- Peak: 1-2hrs
- Duration: 4hrs
- Route: SQ
- risk for low BG at peak action
- admin 3x daily w/ meals
Short Acting Insulin
- Regular
- Onset: 0.5-1hr
- Peak: 2-3hrs
- Duration: 8hrs
- Route: SQ or IV
- risk for low BG at peak action
- dose: hrly per protocol
Long Acting Insulin
- Glargine (Lantus)
- Onset: gradual
- Peak: none
- Duration: up to 24hrs
- Route: SQ
- lower risk for flow BG
- admin 1-2x daily (12-24hrs)
- aka basal insulin, given in lower volumes
x
Hypoglycemia (Causes & CMs)
- Causes:
> too much insulin or other antidiabetic
> too little food
> excess physical exercise - CMs:
> cool, clammy skin, tremors, headache, hunger, irritability, change in LOC
> progression: hypotension, tachycardia, fainting, seizures, coma, death
Hypoglycemia Management - Conscious & Able to Eat Pt
- BG <70
- Give pt 15g rapid-acting simple carbo (sugar)
> 4 glucose tabs; 3tsp of sugar; 1/2c juice (most common); 1c milk; 4oz soda - Recheck BG in 15 mins
- Repeat until BG >80
- Once >80, recheck BG in 1hr, call PCP if <70 still
Hypoglycemia Management - Unconscious or NPO Pt
- IV access: admin 25-50mL D50W IV push
- No IV access: admin Glucagon 1mg SQ/IM; turn pt on side; START IV
- Recheck BG in 15 mins; call PCP for further orders
- Repeat until BG above >80
- Once pt able to swallow give 30g carbo
- Recheck BG in 1 hr; if BG <70 call PCP
Prednisone (Systemic Corticosteroids)
MOA
Indication
Contraindication
D-D
AE
- MOA: anti-inflamm & immunosuppressive effects
- Indication: inflammatory & allergic disorders
- Contraindications: acute infection, DM, acute peptic ulcers, CHF, older adult
- Drug-Drug: quinolone antibiotics, NSAIDS, immunosuppressants, live vaccines
- AE:
> short term: gastric irritation, immunosuppression, edema (HTN, weight gain), insomnia, appetite incr, masks s/s of infection, steroid psychosis
> long term: Cushing’s syndrome, hypernatremia, hypokalemia, growth suppression (children); adrenal suppression
Cushing’s Syndrome
- Weight gain/redistribution of fat
> Moon face
> Buffalo hump
> Pendulous abdomen and stretch marks - Hyperglycemia
- Osteoporosis
- Hypertension
- Muscle atrophy (arms/legs)
- Bruise easily/purpura
- Skin thins/poor healing
Review slides 12, 14, 15 of endocrine drugs on wk 5
Nursing Assessment - Corticosteroids
- Physical exam focused on cardiac, respiratory, neuron, s/s infection
> monitor VS closely for HTN, fever - Labs: CBC, creatinine/BUN, electrolytes (Na/K), BG
Nursing Diagnosis - Corticosteroids
- Excess fluid volume r/t water/sodium retention
- Risk for infection r/t immunosuppression
Expected Outcomes - Corticosteroids
- Therapeutic effect w/ limited AEs
- Understanding of drug therapy, AEs, safety
Nursing Interventions - Corticosteroids
- Admin in morning (normal peak diurnal concentration) & multiple dose in equal intervals (homeostasis)
- Take w/ food
- Taper dose when d/c long term use or from high doses
- Do not give live vaccines when immunosuppressed (risk infection)
- Avoid unnecessary exposure to infection
- Educate: avoid infections, taking dose as appropriate, s/s adrenal crisis, managing AEs
Nursing Evaluation - Corticosteroids
- Therapeutic response
- AEs
- Teaching; was it effective?
Levothyroxine (Synthroid) (Thyroid Agents)
MOA
Indication
AEs (CMs)
BB
Nursing
- MOA: replaces hormones
- Indication: hypothyroidism
- AE: r/t too much med (hyperthyroidism); need PCP to adjust dose
>CMs: nervousness, insomnia, tremors, tachycardia, palpitations, angina, arrhythmias, diaphoresis, heat intolerance - BB: contraindicated for weight loss
- Nursing: teach; take med at same time every day on EMPTY STOMACH
> report: CMs, assess & monitor BP + pulse, monitor TSH lvls
Vasopressin (Synthetic ADH)
MOA
Indications
AEs
Nursing
- MOA: incrs water permeability in renal tubular cells resulting in dcrd urine vol & incrd urine osmolality (incrs reabsorption of water)
- Indications: neurogenic diabetes insipidus; severe hypotension
- AE: r/t too much med (Syndrome of inappropriate antidiuretic hormone secretion); need PCP to adjust med
> SIADH: water intox/cerebral edema (hyponatremia, HTN, seizures, coma)
> high doses: direct vasoconstriction; HTN - Nursing: monitor BP, HR, urine specific gravity, plasma/urine osmolality, serum electrolytes, s/s of hyponatremia
Estrogen (Hormone Replacement Therapy)
MOA
Indication
Route
Contraindictions
AEs
- MOA: replace endogenous estrogen
- Indication: vasomotor symptoms of menopause, uterine bleeding, osteoporosis, atrophic vaginitis, cancers & more
- Route: oral, transdermal, topical
- Contraindications: pregnancy, hx of VTE
- AE: VTE, photosensitivity (BEGEL(S))
- BB: endometrial & breast cx, cardiovascular events
Nursing Assessment - HRT/Estrogens
- Menstrual hx
- Last PAP/breast exam
- Hx of VTE
- Tobacco use